NEWSROOM

PRISM MarketView

BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference

BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference

Apr 2, 2024

BioStem CEO, Jason Matuszewski, will present on Tuesday, April 9, 2024, at 12:30 pm ET POMPANO BEACH, FLORIDA, April 2, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announced that it will present at the 14th Annual LD Micro Invitational Conference at the Sofitel New York on April 8-9, 2024. BioStem’s Chief Executive Officer, Jason...

Blackboxstocks Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2023

Blackboxstocks Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2023

Apr 1, 2024

Acquisition of Evtec Progressing Toward Closing Dallas, TX, April 01, 2024 – Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today announced the Company’s financial results for the fourth quarter and year ended December 31, 2023. https://prismmarketview.com/companies/blackbox/ Fourth Quarter and Annual Financial and Operating...

SKYX Reports Record Sales of $58.8 Million for 2023 and Fourth Quarter Record Sales of $22.2 Million as it Continues to Enhance its Market Penetration for Both Retail and Pro Segments

Apr 1, 2024

SKYX reports $22.4 million in cash, cash equivalents, restricted cash, available cash, and investments available for sale as of December 31, 2023, as compared to $16.8 million as of December 31, 2022 MIAMI, FL, April 01, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with 77 pending and issued patents IN THE US and globally and over 60 lighting and home décor websites, with a mission to make...

BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference

BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase

Apr 1, 2024

-Project Continued Growth from Sales of AmnioWrap2®- -Financial Results Conference Call and Webcast on Monday, April 1, 2024 at 4:30 pm EDT- POMPANO BEACH, FLORIDA, April 1, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the fourth quarter and twelve months ended December 31, 2023. Jason Matuszewski, CEO of BioStem,...

6th Colombia Oil and Gas Congress 2024

Apr 1, 2024

New York City, April 01, 2024 6th Colombia Oil and Gas Congress 2024 Date and Place: July 24th and 25th, 2024, Bogota, ColombiaOrganizer: Vostock Capital Official Web site For the sixth consecutive year, Colombia Oil and Gas 2024 will attract high-level attendees, flagship oil and gas companies from Latin America, world suppliers for the industry, mines and energy ministry members, and journalists to continue networking, share ideas and experience, develop contingency plans together, and work...

Vocodia Launches Pilot Program with Major Utility Provider

Vocodia Launches Pilot Program with Major Utility Provider

Mar 28, 2024

Company’s Conversational AI to Provide 3rd Party Verification for Switching Energy Providers CHICAGO, March 28, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI) ("Vocodia" or the "Company"), an AI software company that builds practical AI functions, today announced that it has signed an agreement with a large utility services company to launch a pilot program for third party verification to switch energy providers. Vocodia’s solutions can automate this labor intensive function by deploying its...

American Shared Hospital Services Reports Fourth Quarter 2023 Financial Results

American Shared Hospital Services Reports Fourth Quarter 2023 Financial Results

Mar 27, 2024

- Acquisition of 3 Rhode Island Radiation Therapy Cancer Centers progressing toward closing- - International Cancer Center equipment upgrade completed in Ecuador, Opening new Puebla, Mexico Center in Q2- - Lease extensions signed at 4 of 10 Gamma Knife customer sites – -Sales Pipeline continues to advance- -Conference Call Thursday, March 28th at 12:00 pm ET / 9:00 am PT - SAN FRANCISCO, CA, March 27, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company") a leading...

Vocodia Launches Pilot Program with Major Utility Provider

CORRECTION – Vocodia Announces Founder and Management Team Investments in Company IPO

Mar 27, 2024

In a release issued under the same headline yesterday, March 26th, please note that the date of Vocodia's IPO completion should be February 26th, not February 22nd, as previously stated. The corrected release follows: CHICAGO, March 27, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI) ("Vocodia" or the "Company"), an AI software company that builds practical AI functions, today announced that the Company’s senior management team invested in Vocodia’s Initial Public Offering (“IPO”) that was...

SKYX Announces Corporate Update Call

Mar 27, 2024

Company to Present Fourth Quarter and 2023 Full Year Financial Results; Conference Call on April 1st, 4:30 PM EST MIAMI, FL, March 27, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive platform technology company with over 77 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become safe-advanced and smart as the new standard, announced today that it will host a Corporate Update...

Sono-Tek to Present at The LD Micro Invitational XIV

Sono-Tek to Present at The LD Micro Invitational XIV

Mar 27, 2024

Presentation on Tuesday, April 9, 2024, at 8:30 am ET MILTON, NY, March 27, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it will be presenting at the 14th Annual LD Micro Invitational at the Sofitel New York on April 8th-9th, 2024. The event is expected to feature 80 companies presenting in half-hour increments, as well as private 1:1 meetings. Sono-Tek is scheduled to present on Tuesday, April 9,...

Vocodia Launches Pilot Program with Major Utility Provider

Vocodia Holdings’ AI Technology Featured in USA Today

Mar 27, 2024

Article highlights Company’s AI-Driven Solutions to Call Center Challenges CHICAGO, March 27, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI) ("Vocodia" or the "Company"), an AI software company that builds practical AI functions, has been recognized in a USA Today article for its innovative solutions that aim to enhance the customer service experience by eliminating call center hold times. The piece, titled “Vocodia’s Conversational AI Eliminates Call Center Hold Times,” highlights the...

American Shared Hospital Services Reports Fourth Quarter 2023 Financial Results

American Shared Hospital Services Pays Tribute to Ernest A. Bates, M.D., Founder and Former Chairman and CEO

Mar 26, 2024

Dr. Bates, Pioneering Neurosurgeon and Philanthropist, passed on March 19, 2024 SAN FRANCISCO, CA, March 26, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that Company Founder, former Chairman and Chief Executive Officer, and Board Director, Ernest A. Bates, M.D, passed away on Tuesday, March 19th at the age of...

Vocodia Launches Pilot Program with Major Utility Provider

Vocodia Announces Founder and Management Team Investments in Company IPO

Mar 26, 2024

CHICAGO, March 26, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI) ("Vocodia" or the "Company"), an AI software company that builds practical AI functions, today announced that the Company’s senior management team invested in Vocodia’s Initial Public Offering (“IPO”) that was completed on February 22, 2024. Brian Podolak, Co-Founder, Chief Executive Officer and Director of Vocodia, invested $400,000 through the purchase of 94,117 units of the IPO. James Sposato, Co-Founder, Chief...

PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024

Mar 25, 2024

New York, N.Y., March 25, 2024 - PRISM MarketView - Drug development is an arduous, costly and time-consuming process for the teams involved behind the scenes, and the patients anxiously awaiting breakthroughs in different disease areas. It takes 12 years on average for a company to take a drug from discovery to commercialization, and every hard-won FDA approval is a cause for celebration for researchers, companies and the end-users whose lives may be changed by these treatments. The past few...

Nutra Pharma Corp. Reaches Settlement with SEC

Mar 22, 2024

Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the company Coral Springs, Florida, March 22, 2024 - Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) earlier this week. On March 19, 2024, the United States District Court for the Eastern District of New York in SEC v. Nutra Pharma Corporation, Erik Deitsch a/k/a Rik Deitsch, and Sean...

American Shared Hospital Services Announces Fourth Quarter 2023 Earnings Conference Call

American Shared Hospital Services Announces Fourth Quarter 2023 Earnings Conference Call

Mar 22, 2024

Conference Call on Thursday, March 28th at 12:00 pm ET / 9:00 am PT SAN FRANCISCO, CA, March 22, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a conference call to discuss its fourth quarter 2023 financial results on Thursday, March 28th at 12:00 pm ET / 9:00 am PT. The fourth quarter...

TransGlobal Assets Inc. Ventures into Pet Health Industry through Strategic Joint Venture

TransGlobal Assets Inc. Ventures into Pet Health Industry through Strategic Joint Venture

Mar 21, 2024

Cheyenne, WY, March 21, 2024 - TransGlobal Assets Inc. (OTC: TMSH) is excited to announce a significant milestone as its wholly owned subsidiary, Better Health Sciences Inc., has entered into a Joint Venture Agreement with Better Health Sciences For Pets Corp., otherwise known as the Better Pets brand. This Joint Venture agreement outlines a strategic collaboration focused on marketing and distributing new key products from Better Pets. Under the terms of the agreement, TransGlobal Assets...

BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference

BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024

Mar 21, 2024

Conference Call on Monday, April 1st, at 4:30 pm ET POMPANO BEACH, FLORIDA, March 21, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today that it plans to release its fourth quarter 2023 financial results post-market Monday, April 01, 2024. BioStem will host a conference call and webcast at 4:30 pm ET on Monday, April 01, 2024....

PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

Mar 18, 2024

New York, N.Y., March 18, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights the FDA’s landmark approval of Rezdiffra™ and the companies leading the charge in developing new, safe, and effective treatments for liver disease. The landmark decision has shone a light on metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic fatty liver disease, a leading cause of liver-related mortality that affects between...

SKYX to Participate in the 36th Annual ROTH Conference

Mar 18, 2024

MIAMI, FL, March 18, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive platform technology company with over 77 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become safe-advanced and smart as the new standard, announced today that management will participate in the 36th Annual ROTH Conference, which is being held March 17-19, 2024 in Dana Point, California. Founder and...

EMPIRE PETROLEUM ANNOUNCES COMMENCEMENT OF PREVIOUSLY ANNOUNCED RIGHTS OFFERING

EMPIRE PETROLEUM ANNOUNCES COMMENCEMENT OF PREVIOUSLY ANNOUNCED RIGHTS OFFERING

Mar 7, 2024

TULSA, Okla., March 7, 2024 - Empire Petroleum Corporation (NYSE American: EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, announced today that it has commenced its previously announced subscription rights offering (“Rights Offering”) pursuant to which it intends to raise gross proceeds of up to approximately $25.0 million. The Company is distributing at no charge to holders of its...

PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

Mar 7, 2024

New York, N.Y., March 07, 2024 - PRISM MarketView announces the release of an insightful interview with Lipella Pharmaceuticals’ CEO, Dr. Jonathan Kaufman, discussing the company's recent regulatory accomplishments and how investors stand to benefit. Lipella Pharmaceuticals was recently granted Orphan Drug Designation by the FDA for LP-410, its drug candidate for oral Graft-versus-Host Disease (GvHD) and previously received Orphan Drug Designation for LP-10 in 2023. With these nods from the...

Free report about the status of the desalination industry in Latin America

Mar 6, 2024

New York City, March 06, 2024 Get the free report about status of desalination industry in Latin America As a preamble to the upcoming 6th Congress and Exhibition Desalination Latin America 2024, which will take place next week in Santiago de Chile on March 13th and 14th, Vostock Capital is pleased to share the results of the annual survey conducted by our research team. The survey inquired about the perspectives, trends, challenges, and opportunities for the desalination industry in the Latin...

SKYX Enters Collaboration with Golden Lighting to Introduce Smart Plug & Play Products into Expanded Sales Channels

SKYX Enters Collaboration with Golden Lighting to Introduce Smart Plug & Play Products into Expanded Sales Channels

Mar 6, 2024

New York, March 06, 2024 - PRISM MediaWire - SKYX Platforms Corp. (Nasdaq: SKYX) announces a strategic partnership with Golden Lighting, a renowned manufacturer and premier provider of elegant lighting solutions. This collaboration aims to facilitate SKYX's introduction of innovative smart and advanced plug & play products to a broader spectrum of online, builder, and professional clientele. https://prismmarketview.com/companies/skyx-platforms-corp/ Rani Kohen, Founder and Executive...

SensaSure Technologies and Verde Bio Holdings File Registration Statement for Previously Announced Merger

Mar 5, 2024

LAS VEGAS, NV, March 05, 2024– SensaSure Technologies, Inc. (OTCQB: SSTC) (“SensaSure”) and Verde Bio Holdings, Inc. (OTC: VBHI) ("Verde" or the "Company"), a growing oil and gas company with a focus on the acquisition and management of oil and gas minerals and royalties, today announced the filing of a Registration Statement on Form S-4 (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) in connection with the previously announced merger between the Company...

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline

Mar 5, 2024

Clinical testing of LP-410 expected to commence in Q2 2024 Pittsburgh, PA, March 05, 2024 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for clinical testing of LP-410 in the treatment of oral Graft-Versus-Host Disease (GVHD). Lipella’s...

Desalination Projects on Construction and Modernization in Latin America

Feb 29, 2024

New York City, February 28, 2024 Get for free the full list of desalination projects on construction and modernization in Latin America We are delighted to inform that Vostock Capital team has prepared a report called Desalination projects Latin America. The report includes all Latin America projects for desalination plants. The report was prepared prior to the 6th International Conference and Exhibition Desalination Latin America (13-14 March, 2024 –...

PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day

PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day

Feb 29, 2024

New York, N.Y., February 29, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, recognizes the remarkable contributions of companies developing treatments for the 10,000 rare diseases affecting more than 30 million Americans. All areas of medicine, and all organs and body systems, are impacted by rare diseases, including rare neurological and neuromuscular diseases, metabolic, skin and bone diseases, and chromosomal disorders. Approximately 95% of rare...

Discover the latest innovations at the Desalination Latin America 2024 Congress

Feb 28, 2024

New York City, February 28, 2024 Discover the latest innovations at the Desalination Latin America 2024 Congress Registration is now open Date: 13-14 March 2024Location: Santiago, ChileOfficial WebsiteOrganizer: Vostock Capital The 6th Conference and exhibition “Desalination Latin America 2024” focuses on the latest achievements in desalination industry in Latin America. The event is dedicated to building business connections, showcasing the new desalination projects and innovations and...

Metatron Apps and AB International Group Join Forces to Launch AI enhanced Movie Streaming Hub

Metatron Apps and AB International Group Join Forces to Launch AI enhanced Movie Streaming Hub

Feb 27, 2024

Dover, DE, February 27, 2024 - In an initiative aimed at revolutionizing the global digital entertainment landscape, Metatron Apps Inc. (OTC: MRNJ) and AB International Group (OTC: ABQQ) have accepted the initial terms of a collaboration via Letter of Intent. Metatron Apps brings to the table a rich history of developing hundreds of mobile apps, with several achieving top 20 rankings on the Apple App Store. AB International Group contributes its streaming rights for over 1000 Chinese movies...